The sociability spectrum: evidence from reciprocal genetic copy number variations.
Alejandro López-Tobón, Sebastiano Trattaro, Giuseppe Testa
PMID 32546261WHAT IT FOUND
Genetic deletions and duplications at specific chromosomal sites cause opposite social outcomes.
Deletion of 7q11.23 causes Williams syndrome, marked by hypersociability with preserved language skills. Duplication of the same region causes autism-like traits with severe speech impairment. These findings describe genetic mechanisms, not treatment effects.
Key findings
01Deletion of the 7q11.23 locus causes Williams-Beuren syndrome, characterized by hypersociability, intellectual disability, and preserved language skills.
02Duplication of the 7q11.23 locus causes 7dupASD, characterized by autism spectrum disorder, cognitive abnormalities, and language impairment.
03Variations in the 15q11-q13 locus cause Angelman syndrome (hypersociability, speech impairment) and Prader-Willi syndrome (ASD, intellectual disability), depending on parental origin.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a review, not a clinical trial, so it provides no evidence on the efficacy of any therapeutic intervention. Many mechanistic insights are derived from animal models or in vitro studies (iPSCs, organoids) that have not yet been validated in human clinical populations. The review acknowledges that genetic heterogeneity and variable penetrance make it difficult to link specific genes to precise behavioral outcomes without large-scale confirmation. The paper does not report new patient data or outcomes from a specific clinical cohort.
Declared interests
The authors declare no competing interests. The work was supported by non-U.S. government funding.
The easy way to misread this
Do not interpret these genetic findings as evidence that targeting these pathways (e.g., with oxytocin or specific inhibitors) will improve social communication in patients. The review explicitly states that such treatments have not been conclusive in clinical trials and that the mechanisms are complex and often not fully penetrant.